Sree Rayalaseema Hi-Strength Hypo Intrinsic Value
Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) median intrinsic value is ₹480.00 from 9 valuation models (range ₹347–₹819), vs current price ₹487.75 — -1.6% downside (Trading Near Calculated Value), margin of safety -1.6%. For current market price and key ratios, visit SRHHYPOLTD stock overview.
SRHHYPOLTD Valuation Methods Summary — DCF, Graham Number & P/E
Sree Rayalaseema Hi-Strength Hypo intrinsic value across 9 models vs current price ₹487.75 — upside/downside and value range per method. Browse SRHHYPOLTD income statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹651.36 | ₹521.09 - ₹781.63 | +33.5% | EPS: ₹54.28, Sector P/E: 12x |
| Book Value Method | asset | ₹548.82 | ₹493.94 - ₹603.70 | +12.5% | Book Value/Share: ₹548.82, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹357.65 | ₹321.88 - ₹393.42 | -26.7% | Revenue/Share: ₹447.06, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹480.00 | ₹432.00 - ₹528.00 | -1.6% | EBITDA: ₹136.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹360.43 | ₹288.34 - ₹432.52 | -26.1% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹347.39 | ₹312.65 - ₹382.13 | -28.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹447.27 | ₹402.54 - ₹492.00 | -8.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹541.18 | ₹487.06 - ₹595.30 | +11.0% | ROE: 9.9%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹818.71 | ₹736.84 - ₹900.58 | +67.9% | EPS: ₹54.28, BVPS: ₹548.82 |
SRHHYPOLTD Intrinsic Value vs Market Price — All Valuation Models
Sree Rayalaseema Hi-Strength Hypo fair value range ₹347–₹819 vs current market price ₹487.75 across 9 valuation models. Compare with Sree Rayalaseema Hi-Strength H valuation methods to assess whether the stock is under or overvalued.
SRHHYPOLTD Intrinsic Value Analysis — Undervalued or Overvalued?
Sree Rayalaseema Hi-Strength Hypo median intrinsic value ₹480.00, current price ₹487.75 — Trading Near Calculated Value by 1.6%, margin of safety -1.6%.
What is the intrinsic value of SRHHYPOLTD?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) is ₹480.00 (median value). With the current market price of ₹487.75, this represents a -1.6% variance from our estimated fair value.
The valuation range spans from ₹347.39 to ₹818.71, indicating ₹347.39 - ₹818.71.
Is SRHHYPOLTD undervalued or overvalued?
Based on our multi-method analysis, Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) appears to be trading near calculated value by approximately 1.6%.
SRHHYPOLTD Financial Health — Key Ratios vs Industry Benchmarks
Sree Rayalaseema Hi-Strength Hypo financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.07 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SRHHYPOLTD Cash Flow Quality — Operating & Free Cash Flow
Sree Rayalaseema Hi-Strength Hypo operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹66 Cr | ₹62 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹140 Cr | ₹130 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹141 Cr | ₹85 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹60 Cr | ₹60 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹71 Cr | ₹14 Cr | Positive Free Cash Flow | 7/10 |